Paid Clinical Trials in Greensboro, NC
As of June 2026, 119 paid clinical trials are recruiting in Greensboro, North Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Greensboro offers studies at sites including Cone Health Cancer Center for conditions such as Obesity, Heart Failure, Malignant Solid Neoplasm, Overweight. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Greensboro
Trials by drug in Greensboro
Filter results
119 clinical trials
↓ Download CSVEvaluating a Digital Intervention to Improve Adolescent Condom Use and Communication
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Post-refractive IOL Outcomes With Clareon TruPlus
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Menopausal HT for Women Living With HIV (HoT)
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Low Energy Availability and Hypertension in Division I HBCU Athletes
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Clinical Evaluation of WaveLight Plus LASIK
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
E-Mindfulness Approaches for Living After Breast Cancer
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
About research studies in Greensboro
Greensboro has approximately 119 recruiting research studies across a wide range of therapeutic areas. North Carolina hosts Duke University Medical Center, UNC Health, and Wake Forest Baptist Health, with strong programs in oncology, cardiovascular disease, and translational research anchored by Research Triangle Park.
Top Research Study Locations in Greensboro
Researchers run research studies in Greensboro, NC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cone Health Cancer Center | Malignant Solid Neoplasm, Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8 | 20 |
| Cone Health Cancer Center at Drawbridge Parkway | Breast Cancer, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 15 |
| Medication Management | Obesity, Overweight, Atherosclerotic Cardiovascular Disease (ASCVD) | 5 |
| Novant Health Breast Surgery - Greensboro | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer | 5 |
| Moses H. Cone Memorial Hospital | Heart Failure, Acute Decompensated Heart Failure, Atrial Enlargement | 4 |
| Triad Clinical Trials | Alzheimers Disease, COPD, Tophaceous Gout | 4 |
| Headache Wellness Center | Episodic Migraine, Migraine Prophylaxis, Migraine | 4 |
| UNC Greensboro | Active Citizenship, Aerobic Exercise, Alzheimer Disease | 3 |
| Pulmonix LLC | Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Interstitial Lung Disease | 3 |
| Carolina Kidney Associates | Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Kidney Disease, Chronic | 2 |
| Cone Health | Breastfeeding Continuation, Breastfeeding Duration, Breastfeeding Self-Efficacy | 2 |
| GSK Investigational Site | HIV Infections | 2 |
| Headache Wellness Center, PC | Acute Treatment of Migraine, Pediatric Migraine | 2 |
| Kailera Clinical Site | Obesity, Obesity With Diabetes, Overweight With Diabetes | 2 |
| Medication Management LLC | Cardiovascular Disease, Cardiovascular Disease and Lipoprotein(a) | 2 |
| Medication Management, LLC | Chronic Cutaneous Lupus Erythematosus, Heart Failure, Subacute Cutaneous Lupus Erythematosus | 2 |
| Medication Mgmnt, LLC_Grnsboro | Heart Failure, Obesity | 2 |
| Moses H Cone Memorial Hospital | Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Obesity | 2 |
| Moses H. Cone Memorial Hospital Operating Corporation d/b/a Cone Health | Heart Failure, Heart Failure With Reduced Ejection Fraction, Moderate Aortic Valve Stenosis | 2 |
| PharmQuest | Chronic Low-back Pain, Diabetes Mellitus, Type 2, Diabetic Neuropathic Pain | 2 |
| PharmQuest Life Sciences LLC | Obesity, Type 2 Diabetes | 2 |
| PulmonIx, LLC | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Cancer | 2 |
| Triad Clinical Trials, LLC | Cardiovascular Disease, Uncontrolled Gout | 2 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 2 |
| Regional Center for Infectious Diseases | HIV Pre-Exposure Prophylaxis, Human Immunodeficiency Virus (HIV), Human Immunodeficiency Virus Type 1 (HIV-1) Infection | 2 |
Active & Upcoming Studies in Greensboro (2026)
Recruiting trials in Greensboro grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (27 active studies)
- Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors · Phase 3 · SWOG Cancer Research Network
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
Cardiovascular (17 active studies)
- Low Energy Availability and Hypertension in Division I HBCU Athletes · North Carolina Agriculture & Technical State University
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation · Phase 2 · Regeneron Pharmaceuticals
Diabetes & metabolic (12 active studies)
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight · Phase 3 · Novo Nordisk A/S
Neurology & pain (9 active studies)
- A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years · Phase 3 · AbbVie
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
HIV / STI (7 active studies)
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
- Menopausal HT for Women Living With HIV (HoT) · Phase 4 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Mental health & behavior (2 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Eye & vision (2 active studies)
- Post-refractive IOL Outcomes With Clareon TruPlus · Laser Defined Vision
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Greensboro
- Obesity (9 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Heart Failure (6 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Malignant Solid Neoplasm (5 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Overweight (5 active studies). Recruiting Overweight studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Greensboro
- AstraZeneca
- Eli Lilly and Company
- National Cancer Institute (NCI)
- Novo Nordisk A/S
- AbbVie
Local regulations and guidelines
Clinical trials in North Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. North Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Greensboro. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Greensboro
Hipa.ai aggregates every recruiting study in Greensboro from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Greensboro?
There are approximately 119 recruiting clinical trials in Greensboro, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Greensboro pay participants?
Most recruiting trials in Greensboro compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Greensboro?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Greensboro?
The most common conditions under active study in Greensboro include Obesity (9), Heart Failure (6), Malignant Solid Neoplasm (5), Overweight (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Greensboro?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Greensboro on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Greensboro?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Greensboro?
Recruiting research sites in Greensboro include Cone Health Cancer Center, Cone Health Cancer Center at Drawbridge Parkway, Medication Management, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Greensboro right now?
The largest active categories in Greensboro are Cancer & tumors (27), Cardiovascular (17), Diabetes & metabolic (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.